Berlin, July 10, 2019 – A diagnosis of "cancer" usually comes out of the blue for patients and their relatives and turns their lives upside down. From that moment on, everything revolves around the disease, and all aspects of daily life must be reorganized. Feelings of uncertainty and anxiety are common, but where can reliable information be found? Since July 1, 2019, concerned persons can go to www.mein-krebs-mein-weg.de
Information and orientation for cancer patients
“My cancer, my way.” Because every cancer and every cancer therapy is different.
The information portal aims to help patients and relatives alleviate their fears about the disease and its treatment and to assist them as companions and navigators during this difficult time. Medical and professional expertise is essential in this regard: Advice and expert contributions are intended to help cancer patients cope more effectively with the disease in their everyday lives and to provide an understanding of how to maintain the highest possible quality of life during treatment.
Focus on service materials and experts
At www.mein-krebs-mein-weg.de, visitors will find a clear overview of the possible stages of treatment and the numerous counselling and support services. The guide includes information about diagnosis, treatment, social and current affairs as well as concrete tools: Professional service materials help patients prepare for appointments free of charge, and articles published on a regular basis provide information about current topics and developments in cancer research. Unlike previous patient websites, “My Cancer, My Way” doesn’t specifically focus on an individual cancer but addresses all cancer patients and their families.
The goal is to become the first place where patients go for information after being diagnosed by a doctor and to provide them with a companion during the disease in “My Cancer, My Way.” In addition, the content-related offering is to be continuously expanded, and further partners are to be added. RIEMSER Pharma GmbH is the founding sponsor.
About Riemser Pharma GmbH
Riemser Pharma GmbH was established in 1992 and emerged from the Friedrich Löffler Institute on Riems Island (Greifswald). Riemser has been in business for more than 25 years, during which it has evolved from a manufacturer of veterinary medicines to a successful provider of specialty pharmaceuticals for therapeutic niches in the field of human medicine.
Riemser sells, licenses, markets and distributes pharmaceutical products. Over 400 approvals worldwide, of which 28 took place in the last three years, are a testament to the special expertise of Riemser for the approval and opening of new markets for pharmaceutical products.
The product range especially covers prescription drugs to treat serious diseases in the therapeutic areas of oncology, infectiology, neurology, in the cardiovascular field, in dermatology, rheumatology, tuberculosis treatment, for the treatment of obesity and primary axillary hyperhidrosis. Medicinal products and food supplements complement the portfolio.
Besides its international group headquarters in Berlin, the company has three locations in Germany. In 2014 and 2015 Riemser acquired the subsidiaries Keocyt based in France and Intrapharm based in England. In addition, it has established an international distribution network. Riemser is a portfolio company of Ardian, one of the world’s leading private investment companies.
For more information, please visit www.riemser.com.
Riemser Pharma GmbH
Dr. Marlies Michaelis
Tel: +49 30 338427- 405
Tel: +49 30 338427-100
Yupik PR GmbH
Tel: 0221 – 130 560 60